Vivo Bio Tech Limited
What company does?Biotechnology research and development
Established2007
Entity typePrivate
HeadquartersIndia
SegmentB2B,B2C
Vivo Bio Tech Limited is a share market listed company
in the Biotechnology industry
.
It got listed on NSE on 17-AUG-2026 under the trading symbol VIVOBIOT.
On BSE it is listed under trading symbol VIVOBIOT.
The company operates in
Biotechnology
,
Pharmaceuticals
and
Health Care
categories.
Company overview
Vivo Bio Tech Ltd. is a leading biotechnology company that specializes in the development and commercialization of innovative products for the healthcare industry. The company is dedicated to advancing medical research, drug discovery, and diagnostics through its cutting-edge technologies.
Vivo Bio Tech's primary focus lies in developing novel therapies and diagnostic tools for various diseases, including cancer, cardiovascular disorders, infectious diseases, and neurological conditions. The company leverages state-of-the-art biotechnologies to create advanced solutions that address unmet medical needs.
One of Vivo Bio Tech's standout products is its proprietary line of precision medicine offerings designed to provide personalized treatment options for patients based on their genetic makeup and specific disease characteristics. This approach helps optimize therapeutic outcomes while minimizing potential side effects.
Vivo Bio Tech has gained recognition for its commitment to innovation and scientific excellence within the biotech landscape. Its team of experts continually works towards pushing boundaries in biomedical research and translating discoveries into impactful clinical applications. In addition to its internal R&D efforts, Vivo Bio Tech collaborates with renowned academic institutions, pharmaceutical companies, and healthcare organizations worldwide to foster knowledge exchange and drive collaborative advancements in healthcare technology. The company's dedication to pioneering breakthroughs in biotechnology coupled with strategic partnerships positions it as a formidable player in the global life sciences arena.